HOME > PRODUCT DISPLAY > Chemical

Glipizide Tablets

【Description】This product is a kind of white tablet. 【Indications】It is indicated for the treatment of mild to moderate diabetes II that cannot be satisfactorily controlled through dietetic treatment and physical exercises. 【Administr

Details
Glipizide Tablets

  【Description】This product is a kind of white tablet.

  【Indications】It is indicated for the treatment of mild to moderate diabetes II that cannot be satisfactorily controlled through dietetic treatment and physical exercises.

  【Administration and Dosage】

  This product shall be administered orally. The dosage shall be determined individually according to the specific patient. The recommended dosage is 2.5mg/day to 20mg/day (1/2 tablet to 4 tablets) and it shall be administered 30 minutes before breakfast. If the daily dosage exceeds 15mg (3 tablets) it shall be administered in three separate doses before the meal in the morning, at noon and in the evening respectively.

  For Patients Who Failed with Dietetic Treatment Alone: The initial dosage shall be 2.5mg to 5mg (1/2 tablet to 1 tablet) a day and the dosage shall be increased or decreased according to the blood glucose level and the urine glucose level with an increment or a decrement of 2.5mg to 5mg (1/2 tablet to 1 tablet) each time. If the daily dosage exceeds 15mg (3 tablets), it shall be administered in 2 to 3 separate doses before meals.

  For Patients Who are Using Other Sulfonylurea Hypoglycemics: This product shall be administered after having withdrawn other sulfonyurea hypoglycermics for 3 days and reexamined the blood glucose level. The dosage shall be increased starting from 5mg (1 tablet) until the satisfactory therapeutic effect is achieved. The maximum daily dosage shall not exceed 30mg (6 tablets).

  【Storage】Protect from light, seal and keep in dry place.

  【Package】Aluminum-plastic plate 10 tablets / plate, 3 plates / box

  【Validity】2 years 

  【Approval No.】GYZZ H20056693

Copyright: Shijiazhuang Yiling pharmaceutical Limited by Share Ltd